Longhu Zhou, PhD
Laboratory of Biochemical and Pharmacology (LOBP)
Department of Pediatrics
School of Medicine | Emory University
Dr. Zhou has more than 30 years of synthetic organic experience of which more than 20 years were in drug discovery and development. His research has focused on developing new nucleosides, nucleotides, and small molecule antiviral agents for treatment of HCV, HBV, HIV, dengue, influenza and SARS-Cov-2 virus. He has designed and synthesized several HCV NS5A inhibitors as well as nucleosides and nucleoside pro-drugs as lead antiviral agents. Dr. Zhou has co-authored more than eighty research publications in peer-reviewed journals, and co-inventor of ten patents and/or patent applications.